Molecular determinants of acquired resistance to BRAF inhibition in human lung cancer

We report here the first analysis of mechanisms of secondary resistance to a BRAF inhibitor in a patient with BRAF-mu tated NSCLC by using whole-exome sequencing and functional studies.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research